23 August 2018Americas

LSIPR 50 2018: Craig Muir


Name: Craig Muir

Organisation: Third Rock Ventures

Position: Chief Technology Officer and Partner

Craig Muir works at the intersection of science, strategy, business, and medicine, transforming disruptive technologies into valuable business enterprises which go on to make a dramatic difference to the lives of patients.

In his day-to-day work Muir leads the identification and integration of drug discovery and develops technology platforms for companies across Third Rock Ventures’ portfolio. He assists with the development of systems to best manage research and development and informatics, and contributes to scientific diligence for investment opportunities.

Muir has more than 25 years of experience across the biotechnology and pharmaceutical industries, focusing his work on technology development and application implementation. He played a central role in expanding Third Rock Ventures’ presence in San Francisco, increasing the company’s access to new and innovative technologies through the West Coast.

Given his extensive experience Muir assumes leadership roles in Third Rock Ventures’ portfolio companies by serving as interim chief technology or information officer for the first year or so following the launch. The portfolio of companies he has contributed to in this way include Pliant Therapeutics, Constellation Pharmaceuticals, and Global Blood Therapeutics.

Muir previously worked at Codon Devices as senior vice president of technical operations and also spent 12 years at Millennium Pharmaceuticals as vice president of platform technology. He serves on the Scientific Advisory Board of the Bigelow Laboratory for Ocean Sciences.